According to the Global Alliance for Vaccines and Immunization (Gavi), a Sanofi vaccine designed to prevent acne is undergoing phase one trials. The vaccine aims to restore skin microbiome balance, reduce inflammation and the number of lesions, and decrease the need for prolonged antibiotic or drug use.

Utilizing mRNA technology, this vaccine targets specific strains of acne-causing bacteria and inflammatory pathways. If successful, an acne vaccine could mark the beginning of a new vaccine class. Such injections could not only prevent infectious diseases but also intervene in and modulate the complex relationship between bacteria, the immune system, and chronic diseases.

Beyond Sanofi, numerous other research groups are developing vaccines by neutralizing proteins or enzymes secreted by bacteria—factors believed to trigger inflammatory responses on the skin. This approach is expected to reduce inflammation without significantly disrupting the beneficial microbiome.

A woman looking in the mirror, caring for her face. Photo: Unsplash.

Gavi states that acne vaccines are not yet ready for widespread application. Current trials primarily assess safety, tolerability, and immune response. While initial results are promising, the vaccine must undergo more extensive trial phases before approval, a process that could take many years.

Experts believe the prospects for acne vaccines are significant, especially given the growing demand for safe, sustainable treatments. If successful, this could usher in a new generation of dermatological vaccines, not only combating infections but also modulating inflammatory responses associated with chronic skin conditions.

Acne vulgaris is a common dermatological condition, affecting most adolescents and many adults. Although rarely life-threatening, acne can lead to scarring, pigmentation disorders, and significantly impact psychological well-being and quality of life.

Currently, acne treatment primarily relies on topical medications, antibiotics, or isotretinoin to control lesions and limit scarring. However, these methods cannot prevent acne from appearing in the first place. Prolonged antibiotic use also increases the risk of drug resistance, while isotretinoin requires close monitoring due to potential side effects.

Van Ha